Lipigon Pharmaceuticals AB (publ) (STO:LPGO)
0.0076
+0.0012 (18.75%)
Mar 9, 2026, 5:01 PM CET
-94.57% (1Y)
| Market Cap | 4.61M |
| Revenue (ttm) | 1.32M |
| Net Income (ttm) | -35.97M |
| Shares Out | 605.93M |
| EPS (ttm) | -0.14 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 20,651,632 |
| Average Volume | 7,027,547 |
| Open | 0.0064 |
| Previous Close | 0.0064 |
| Day's Range | 0.0064 - 0.0110 |
| 52-Week Range | 0.0040 - 0.3695 |
| Beta | 0.59 |
| RSI | 45.15 |
| Earnings Date | Feb 20, 2026 |